E
Entrada Therapeutics, Inc. (TRDA)
NGM – Real Time Price. Currency in USD
7.12
+0.12 (1.71%)
At close: May 12, 2026, 4:00 PM EDT
7.10
-0.02 (-0.28%)
After-hours: May 12, 2026, 5:27 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
7.12
+0.12 (1.71%)
At close: May 12, 2026, 4:00 PM EDT
7.10
-0.02 (-0.28%)
After-hours: May 12, 2026, 5:27 PM EDT
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
| Name | Position |
|---|---|
| Dr. Jared Cohen J.D., Ph.D. | General Counsel |
| Dr. Natarajan Sethuraman Ph.D. | President of Research & Development |
| Mr. Dipal Doshi | CEO & Director |
| Mr. Kevin Healy Ph.D. | Senior Vice President of Regulatory Affairs |
| Mr. Kory James Wentworth CPA | CFO & Treasurer |
| Mr. Nathan J. Dowden | President & COO |
| Ms. Karla MacDonald | Chief Corporate Affairs Officer |
| Ms. Kerry Robert M.S. | Senior Vice President of People |
| Sandeep Basnet | Head of Information Technology |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | trda-20260507.htm |
| 2026-05-07 | 10-Q | trda-20260331.htm |
| 2026-04-29 | DEFA14A | tm2613037d1_defa14a.htm |
| 2026-04-24 | DEFA14A | entradatherapeuticsinc-202.htm |
| 2026-04-24 | DEF 14A | trda-20260424.htm |
| 2026-02-26 | 10-K | trda-20251231.htm |
| 2026-01-08 | 8-K | trda-20260108.htm |
| 2025-12-01 | CORRESP | filename1.htm |
| 2025-11-06 | S-3 | tm2530185d1_s3.htm |
| 2025-11-06 | 8-K | trda-20251106.htm |